Literature DB >> 19367706

Identification of RKIP as an invasion suppressor protein in nasopharyngeal carcinoma by proteomic analysis.

Yan Chen1, Guo-Liang Ouyang, Hong Yi, Mao-Yu Li, Peng-Fei Zhang, Cui Li, Jian-Ling Li, Ying-Fu Liu, Zhu-Chu Chen, Zhi-Qiang Xiao.   

Abstract

To identify novel proteins associated with the pathogenesis of nasopharyngeal carcinoma (NPC), a proteomic approach was used to screen for differential proteins between NPC and adjacent noncancerous nasopharyngeal epithelial tissue (ANNET). As a result, 21 differential proteins were identified by two-dimensional electrophoresis and mass spectrometer. Raf kinase inhibitor protein (RKIP), one of the downregulated proteins in NPC compared to ANNET, was investigated for its role in the metastasis of NPC. Western blot analysis and immunohistochemistry were used to detect RKIP expression in 5-8F and 6-10B NPC cell lines with the different metastatic potentials, and in NNET, primary NPC and NPC metastasis. Furthermore, high metastatic 5-8F with low RKIP expression and nonmetastatic 6-10B with high RKIP expression were stably transfected with plasmids that expressed sense and antisense RKIP cDNA, respectively, or with empty vector. The effects of RKIP expression on in vitro cell invasion, and the activity of Raf-1/MEK/ERK signaling pathway were analyzed in the transfected cells. The results showed that RKIP was significantly downregulated in 5-8F compared with 6-10B, in NPC compared with NNET, and not detectable in NPC metastasis. Overexpressed RKIP in 5-8F could decrease its in vitro cell invasion, whereas downregulated RKIP in 6-10B could increase its in vitro cell invasion. RKIP negatively regulated Raf-1/MEK/ERK signaling pathway in NPC cells, and activation of this signaling pathway by RKIP downregulation increased in vitro invasion of NPC cells. Taken together, our results suggest that RKIP may be a NPC metastasis suppressor, and decreased RKIP expression is associated with the increased invasive capability of NPC cells possibly through the activation of Raf-1/MEK/ERK pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19367706     DOI: 10.1021/pr800602c

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  19 in total

1.  Attenuation of mouse melanoma by A/C magnetic field after delivery of bi-magnetic nanoparticles by neural progenitor cells.

Authors:  Raja Shekar Rachakatla; Sivasai Balivada; Gwi-Moon Seo; Carl B Myers; Hongwang Wang; Thilani N Samarakoon; Raj Dani; Marla Pyle; Franklin O Kroh; Brandon Walker; Xiaoxuan Leaym; Olga B Koper; Viktor Chikan; Stefan H Bossmann; Masaaki Tamura; Deryl L Troyer
Journal:  ACS Nano       Date:  2010-11-08       Impact factor: 15.881

2.  Expression of Raf-1 kinase inhibitory protein in carcinoma of the ampulla of Vater.

Authors:  Hyun-Soo Kim; Sun Ho Lee; Kyu Yeoun Won; Gou Young Kim; Yong-Koo Park; Youn Wha Kim
Journal:  Virchows Arch       Date:  2011-11-20       Impact factor: 4.064

3.  Raf-1 kinase inhibitory protein expression in thyroid carcinomas.

Authors:  Hyun-Soo Kim; Gou Young Kim; Sung-Jig Lim; Youn Wha Kim
Journal:  Endocr Pathol       Date:  2010-12       Impact factor: 3.943

4.  Raf kinase inhibitor protein suppresses nuclear factor-κB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression.

Authors:  Anwar B Beshir; Gang Ren; Anniefer N Magpusao; Lauren M Barone; Kam C Yeung; Gabriel Fenteany
Journal:  Cancer Lett       Date:  2010-09-19       Impact factor: 8.679

5.  Positive effect of high RKIP expression on reduced distant metastasis by chemotherapy when combined with radiotherapy in locoregionally advanced nasopharyngeal carcinoma: a prospective study.

Authors:  Si Wei Li; Hua Wang; Mei Lian Liu; Hai Bo Zhang; Yan Qun Xiang; Xing Lv; Wei Xiong Xia; Mu Sheng Zeng; Hai Qiang Mai; Ming Huang Hong; Xiang Guo
Journal:  Med Oncol       Date:  2012-12-15       Impact factor: 3.064

6.  A five-variable signature predicts radioresistance and prognosis in nasopharyngeal carcinoma patients receiving radical radiotherapy.

Authors:  Hong-Mei Yi; Hong Yi; Jin-Feng Zhu; Ta Xiao; Shan-Shan Lu; Yong-Jun Guan; Zhi-Qiang Xiao
Journal:  Tumour Biol       Date:  2015-09-27

7.  Identification of tyrosine phosphoproteins in signaling pathway triggered TGF-a by using functional proteomics technology.

Authors:  Lin Ruan; Guo-Liang Wang; Yan Chen; Hong Yi; Can-E Tang; Peng-Fei Zhang; Mao-Yu Li; Cui Li; Fang Peng; Jian-Ling Li; Zhu-Chu Chen; Zhi-Qiang Xiao
Journal:  Med Oncol       Date:  2010-01-05       Impact factor: 3.064

8.  Identification of galectin-7 as a potential biomarker for esophageal squamous cell carcinoma by proteomic analysis.

Authors:  Xi Zhu; Ming Ding; Mei-Lan Yu; Ming-Xiang Feng; Li-Jie Tan; Fu-Kun Zhao
Journal:  BMC Cancer       Date:  2010-06-15       Impact factor: 4.430

9.  RKIP inhibition in cervical cancer is associated with higher tumor aggressive behavior and resistance to cisplatin therapy.

Authors:  Olga Martinho; Filipe Pinto; Sara Granja; Vera Miranda-Gonçalves; Marise A R Moreira; Luis F J Ribeiro; Celso di Loreto; Marsha R Rosner; Adhemar Longatto-Filho; Rui Manuel Reis
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

10.  The functional proteomics analysis of VEGF-treated human epithelial ovarian cancer cells.

Authors:  Fan Zhang; Cui Li; Hailing Liu; Yuexiang Wang; Yile Chen; Xiaoying Wu
Journal:  Tumour Biol       Date:  2014-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.